Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
7 Jul 2020	Submitted	Original manuscript
13 Jul 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
15 Jul 2020	Editorially accepted
8 Aug 2020	Article published	10.1186/s13063-020-04616-4

Back to article page